Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more
Hangzhou Coco Healthcare Products Co.Ltd. (301009) - Total Assets
Latest total assets as of September 2025: CN¥2.15 Billion CNY
Based on the latest financial reports, Hangzhou Coco Healthcare Products Co.Ltd. (301009) holds total assets worth CN¥2.15 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hangzhou Coco Healthcare Products Co.Ltd. - Total Assets Trend (2017–2024)
This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hangzhou Coco Healthcare Products Co.Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Hangzhou Coco Healthcare Products Co.Ltd.'s total assets of CN¥2.15 Billion consist of 61.1% current assets and 39.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.4% |
| Accounts Receivable | CN¥230.47 Million | 11.0% |
| Inventory | CN¥141.88 Million | 6.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥81.68 Million | 3.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hangzhou Coco Healthcare Products Co.Ltd.'s current assets represent 61.1% of total assets in 2024, an increase from 58.1% in 2017.
- Cash Position: Cash and equivalents constituted 29.4% of total assets in 2024, up from 25.5% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 11.0% of total assets.
Hangzhou Coco Healthcare Products Co.Ltd. Competitors by Total Assets
Key competitors of Hangzhou Coco Healthcare Products Co.Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Hangzhou Coco Healthcare Products Co.Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Hangzhou Coco Healthcare Products Co.Ltd. generates 0.52x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Hangzhou Coco Healthcare Products Co.Ltd. generates $ 1.49 in net profit.
Hangzhou Coco Healthcare Products Co.Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.99 | 2.51 | 1.05 |
| Quick Ratio | 1.77 | 2.23 | 0.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥684.27 Million | CN¥ 673.28 Million | CN¥ 43.81 Million |
Hangzhou Coco Healthcare Products Co.Ltd. - Advanced Valuation Insights
This section examines the relationship between Hangzhou Coco Healthcare Products Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.50 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | CN¥2.09 Billion |
| Market Capitalization | $141.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hangzhou Coco Healthcare Products Co.Ltd.'s assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hangzhou Coco Healthcare Products Co.Ltd.'s assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below shows the annual total assets of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.09 Billion | +4.90% |
| 2023-12-31 | CN¥1.99 Billion | +2.23% |
| 2022-12-31 | CN¥1.95 Billion | -6.57% |
| 2021-12-31 | CN¥2.09 Billion | +39.60% |
| 2020-12-31 | CN¥1.49 Billion | +39.37% |
| 2019-12-31 | CN¥1.07 Billion | +7.59% |
| 2018-12-31 | CN¥996.27 Million | +4.09% |
| 2017-12-31 | CN¥957.14 Million | -- |